logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Katherine J Franz

This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignee: Duke University. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katherine J Franz. Retrieved from https://idiyas.com/inventor/katherine-j-franz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 45.5

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal11 out of 2,085 
 
Duke University
 patents

Years Active: 2012-2021

Loading Chart...
11 patents (USPTO):Explore Patents
1. 11007273 - Prochelators as targeted prodrugs for prostate cancer and methods of making and using same (2021-05-18),
2. 10533018 - Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same (2020-01-14),
3. 9526740 - Prochelators as broad-spectrum antimicrobial agents and methods of use (2016-12-27),
4. 9365593 - Photolabile caged transition metal complexes and methods of using the same (2016-06-14),
5. 9333213 - Prochelators as broad-spectrum antimicrobial agents and methods of use (2016-05-10),
6. 9175016 - Prochelators useful for inhibiting metal-associated toxicity (2015-11-03),
7. 8859223 - Compositions and methods for imaging beta-secretase activity in living cells and organisms (2014-10-14),
8. 8680077 - Prochelators useful for inhibiting metal-associated toxicity (2014-03-25),
9. 8551976 - Prochelators for inhibiting metal-promoted oxidative stress (2013-10-08),
10. 8440827 - Photolabile caged transition metal complexes and methods of using the same (2013-05-14),
11. 8236783 - ROS-sensitive iron chelators and methods of using the same (2012-08-07),

Title: Katherine J Franz: Innovator in Cancer Treatment

Introduction

Katherine J Franz is a prominent inventor based in Durham, NC (US), known for her significant contributions to cancer treatment through innovative drug development. With a total of 11 patents, she has made remarkable strides in the field of targeted therapies.

Latest Patents

Her latest patents include "Prochelators as targeted prodrugs for prostate cancer and methods of making and using same," which provides prochelators designed as targeted prodrugs for cancer, specifically prostate cancer. Another notable patent is "Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same," which focuses on antibacterial prodrugs and their manufacturing methods.

Career Highlights

Katherine is affiliated with Duke University, where she continues her research and development efforts. Her work is pivotal in addressing critical health challenges, particularly in the realm of drug-resistant infections and cancer therapies.

Collaborations

Some of her notable coworkers include Marina G D Leed and Katie L Ciesienski, who contribute to her innovative projects and research initiatives.

Conclusion

Katherine J Franz exemplifies the spirit of innovation in the medical field, particularly in cancer treatment and antimicrobial research. Her contributions are vital in the ongoing battle against cancer and drug-resistant bacteria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…